Acetaminophen/paracetamol: A history of errors, failures and false decisions

被引:137
作者
Brune, K. [1 ]
Renner, B. [1 ]
Tiegs, G. [2 ]
机构
[1] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Erlangen, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Inst Expt Immunol & Hepatol, Hamburg, Germany
关键词
ACUTE LIVER-FAILURE; RANDOMIZED CONTROLLED-TRIAL; INDUCED HEPATIC-NECROSIS; PARACETAMOL ACETAMINOPHEN; ANALGESIC NEPHROPATHY; PROTEIN ADDUCT; PREGNANCY; IBUPROFEN; ASTHMA; OVERDOSE;
D O I
10.1002/ejp.621
中图分类号
R614 [麻醉学];
学科分类号
100217 [麻醉学];
摘要
Acetaminophen/paracetamol is the most widely used drug of the world. At the same time, it is probably one of the most dangerous compounds in medical use, causing hundreds of deaths in all industrialized countries due to acute liver failure (ALF). Publications of the last 130 years found in the usual databases were analyzed. Personal contacts existed to renowned researchers having contributed to the medical use of paracetamol and its precursors as H.U. Zollinger, S. Moeschlin, U. Dubach, J. Axelrod and others. Further information is found in earlier reviews by Eichengrun, Rodnan and Benedek, Sneader, Brune; comp. references. The history of the discovery of paracetamol starts with an error (active against worms), continues with a false assumption (paracetamol is safer than phenacetin), describes the first side-effect epidemy' (phenacetin nephropathy, drug-induced interstitial nephritis) and ends with the discovery of second-generation problems due to the unavoidable production of a highly toxic metabolite of paracetamol N-acetyl-p-benzoquinone imine (NAPQI) that may cause not only ALF and kidney damage but also impaired development of the fetus and the newborn child. It appears timely to reassess the risk/benefit ratio of this compound.
引用
收藏
页码:953 / 965
页数:13
相关论文
共 99 条
[91]
Paracetamol (Acetaminophen) Administration During Neonatal Brain Development Affects Cognitive Function and Alters Its Analgesic and Anxiolytic Response in Adult Male Mice [J].
Viberg, Henrik ;
Eriksson, Per ;
Gordh, Torsten ;
Fredriksson, Anders .
TOXICOLOGICAL SCIENCES, 2014, 138 (01) :139-147
[92]
Walton A. G., 2014, PHARM HEALTHCARE
[93]
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily - A randomized controlled trial [J].
Watkins, Paul B. ;
Kaplowitz, Neil ;
Slattery, John T. ;
Colonese, Connie R. ;
Colucci, Salvatore V. ;
Stewart, Paul W. ;
Harris, Stephen C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (01) :87-93
[94]
Acute liver failure in Sweden:: etiology and outcome [J].
Wei, G. ;
Bergquist, A. ;
Broome, U. ;
Lindgren, S. ;
Wallerstedt, S. ;
Almer, S. ;
Sangfelt, P. ;
Danielsson, A. ;
Sandberg-Gertzen, H. ;
Loof, L. ;
Prytz, H. ;
Bjornsson, E. .
JOURNAL OF INTERNAL MEDICINE, 2007, 262 (03) :393-401
[95]
Zebrafish teratogenicity test with metabolic activation (mDarT): Effects of phase I activation of acetaminophen on zebrafish Danio rerio embryos [J].
Weigt, Stefan ;
Huebler, Nicole ;
Braunbeck, Thomas ;
von Landenberg, Friedrich ;
Broschard, Thomas H. .
TOXICOLOGY, 2010, 275 (1-3) :36-49
[96]
WIEGAND UW, 1984, PEDIATR PHARMACOL, V4, P145
[97]
Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial [J].
Williams, Christopher M. ;
Maher, Christopher G. ;
Latimer, Jane ;
McLachlan, Andrew J. ;
Hancock, Mark J. ;
Day, Richard O. ;
Lin, Chung-Wei Christine .
LANCET, 2014, 384 (9954) :1586-1596
[98]
OARSI recommendations for the management of hip and knee osteoarthritis Part III: changes in evidence following systematic cumulative update of research published through January 2009 [J].
Zhang, W. ;
Nuki, G. ;
Moskowitz, R. W. ;
Abramson, S. ;
Altman, R. D. ;
Arden, N. K. ;
Bierma-Zeinstra, S. ;
Brandt, K. D. ;
Croft, P. ;
Doherty, M. ;
Dougados, M. ;
Hochberg, M. ;
Hunter, D. J. ;
Kwoh, K. ;
Lohmander, L. S. ;
Tugwell, P. .
OSTEOARTHRITIS AND CARTILAGE, 2010, 18 (04) :476-499
[99]
ZOLLINGER H U, 1955, Schweiz Med Wochenschr, V85, P746